Youngevity CEO Steve Wallach will be a featured speaker at upcoming CBD Symposium, hosted by SUCCESS Partners and Direct Selling News.
“Unquestionably, CBD has become the hottest topic in the direct-selling channel, and this event presents a prime opportunity for sharing information about CBD and how best to utilize the direct-selling business model in offering this transformative product to the public,” said Wallach.
It has been estimated that direct-selling companies will sell $300 million in CBD-related products in 2018, which would make direct-selling the largest distribution channel for this rapidly growing product sector. Youngevity is well-positioned to capitalize on the expected CBD direct-selling boom. The company recently launched Hemp FX™, a line of hemp-derived CBD products that includes three proprietary formulas that feature Youngevity’s hemp-derived, phytocannabinoid-rich, full-spectrum, organically grown CBD oil, and two tablet-based CBD products in the HempFX™ Hydration™ category.
“Hemp FX is an ideal representation of our plant-based approach to product development,” said Wallach. “These select products are being offered in this initial launch, and we expect the Hemp FX line will continue to grow, with more products becoming available in the near.”
The symposium will take place Nov. 6 in Dallas, Texas.